TrialAntimicrobial agents and chemotherapy2024

Population pharmacokinetic modeling of dolutegravir/lamivudine to support a once-daily fixed-dose combination regimen in virologically suppressed adults living with HIV-1.

Hardik Chandasana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.